⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ADVM News
$191.2 Million Achromatopsia Market Outlook, 2026-2032, Featuring Adverum Biotechnologies, Homology Medicines, Mattel, REGENXBIO, Sanofi and More
globenewswire.com
ADVM
MAT
SNY
Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition
prnewswire.com
LLY
ADVM
March Biosciences Announces Appointment of Gurpreet Ratra, Ph.D., as Chief Business Officer
globenewswire.com
SPRC
ADVM
INXN
Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly
globenewswire.com
ADVM
LLY
Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights
prnewswire.com
BRNS
FITB
ADVM
HBAN
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-HOUS, ADVM, HBAN, and COMP
prnewswire.com
HOUS
ADVM
HBAN
COMP
HALPER SADEH LLC ENCOURAGES ADVM, PLYM, RNA SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
prnewswire.com
ADVM
PLYM
RNA
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders
businesswire.com
ADVM
Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM
businesswire.com
ADVM
LLY
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Adverum Biotechnologies, Inc. (NASDAQ: ADVM)
prnewswire.com
ADVM